SCHEMBL16235075

SCHEMBL16235075

COc1cc(Cl)nnc1NS(=O)(=O)c1ccc(F)c(Cl)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.58
▸ KMT2A Q03164 5/20 0.58
▸ MEN1 O00255 4/20 0.58
▸ LMNA P02545 4/20 0.58
▸ PKM P14618 2/20 0.58
▸ TSHR P16473 2/20 0.58
▸ NPSR1 Q6W5P4 1/20 0.58
▸ HTT P42858 2/20 0.55
▸ MAPT P10636 2/20 0.55
▸ THRB P10828 2/20 0.55
▸ PABPC1 P11940 1/20 0.55
▸ KDM4E B2RXH2 1/20 0.46
▸ S1PR1 P21453 1/20 0.45
▸ S1PR3 Q99500 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ AGTR1 P30556 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ FFAR4 Q5NUL3 1/20 0.43
▸ CCR4 P51679 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16235495 0.81 CCR4 (0.44) ALDH1A1KMT2AMEN1LMNAPKM
SCHEMBL16235036 0.81 MEN1 (0.46) ALDH1A1KMT2AMEN1LMNAPKM
SCHEMBL16235422 0.76 ACLY (0.56) ALDH1A1PKMTSHRMAPTKDM4E
SCHEMBL16235176 0.76 SLC40A1 (0.48) FFAR4
SCHEMBL16234992 0.75 ACLY (0.54) ALDH1A1KMT2AMEN1LMNAPKM
SCHEMBL16235425 0.75 ACLY (0.45) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL5736375 0.74 CCR4 (0.59) ALDH1A1LMNACCR4
SCHEMBL5737260 0.72 SMN1; SMN2 (0.60) KMT2AMEN1HTTMAPTPABPC1
SCHEMBL16235177 0.72 ALDH1A1 (0.50) ALDH1A1KMT2ALMNANPSR1HTT
SCHEMBL4780513 0.71 ALDH1A1 (0.52) ALDH1A1KMT2AMEN1LMNAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10125125-B2 N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors ACTIVE BIOTECH AB (SE) 2018-11-13 — — US disclosed
US-20180155330-A1 N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2018-06-07 — — US disclosed
US-9873687-B2 N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors ACTIVE BIOTECH AB (SE) 2018-01-23 — — US disclosed
US-20160115158-A1 N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2016-04-28 — — US disclosed
EP-2925743-B1 N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2016-02-03 — — EP disclosed
EP-2925743-A1 N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS Active Biotech AB (SE) 2015-10-07 — — EP disclosed
WO-2014184234-A1 N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2014-11-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10125125-B2 N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors S100A9, S100B, S100A10 ALDH1A1 4109/4885KMT2A 3107/4885MEN1 1176/4885
US-20180155330-A1 N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS S100A9, S100B, S100A10 ALDH1A1 4109/4885KMT2A 3107/4885MEN1 1176/4885
US-20160115158-A1 N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS S100A9, S100A4, S100B ALDH1A1 4370/4885KMT2A 4315/4885MEN1 740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback